Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Integrating androgen signaling tumor dependency with host neuroendocrine immunity for glioblastoma therapies. Local targets link to admitted publications; unresolved targets remain external evidence.
Androgen loss accelerates brain tumour growth via HPA axis activation
10.1038/s41586-026-10451-5 · 2026 · External reference
Androgen receptor: a potential therapeutic target for glioblastoma
10.18632/oncotarget.25007 · 2018 · External reference
Androgen receptor activation in glioblastoma can be achieved by ligand-independent signaling through EGFR—a potential therapeutic target
10.3390/ijms222010954 · 2021 · External reference
Intracranial assessment of androgen receptor antagonists in mice bearing human glioblastoma implants
10.3390/ijms25010332 · 2023 · External reference
Expression of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to antiandrogen therapy
10.1158/1535-7163.mct-20-0095 · 2020 · External reference
Small-molecule HSP27 inhibitor abolishes androgen receptors in glioblastoma
10.1021/acs.jmedchem.0c01537 · 2021 · External reference
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
10.1016/j.annonc.2019.12.002 · 2020 · External reference
Females have the survival advantage in glioblastoma
10.1093/neuonc/noy002 · 2018 · External reference
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
10.1038/s41591-019-0566-4 · 2019 · External reference
P06.04.A first in human - targeting androgen receptor for glioblastoma therapy
10.1093/neuonc/noae144.141 · 2024 · External reference
